Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr;34(4):409-420.
doi: 10.1080/09540121.2021.1981816. Epub 2021 Oct 6.

Point-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial

Affiliations
Randomized Controlled Trial

Point-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial

Lindsey K Reif et al. AIDS Care. 2022 Apr.

Abstract

HIV viral load (VL) monitoring can reinforce antiretroviral therapy (ART) adherence. Standard VL testing requires high laboratory capacity and coordination between clinic and laboratory which can delay results. A randomized trial comparing point-of-care (POC) VL testing to standard VL testing among 150 adolescents and young adults, ages 10-24 years, living with HIV in Haiti determined if POC VL testing could return faster results and improve ART adherence and viral suppression. Participants received a POC VL test with same-day result (POC arm) or a standard VL test with result given 1 month later (SOC arm). POC arm participants were more likely to receive a test result within 6 weeks than SOC arm participants (94.7% vs. 80.1%; p1000 copies/ml and low self-reported ART adherence was stronger in the POC arm (OR: 6.57; 95%CI: 2.12-25.21) than the SOC arm (OR: 2.62; 95%CI: 0.97-7.44) suggesting more accurate self-report in the POC arm. POC VL testing was effectively implemented in this low-resource setting with faster results and is a pragmatic intervention that may enable clinicians to identify those with high VL to provide enhanced counseling or regimen changes sooner.Trial registration: ClinicalTrials.gov identifier: NCT03288246.

Keywords: Adolescent; HIV; RCT; adherence; viral suppression; youth.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Flow diagram of participant screening, enrollment, and follow-up
Figure 2.
Figure 2.
Association of sub-optimal self-reported ART adherence and VL ≥1,000 copies/ml at month 6

References

    1. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, & Bunnell R (2006) Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS and Behavior. 10(4 Suppl):S85–93. doi: 10.1007/s10461-006-9141-3 - DOI - PubMed
    1. Belzer ME, MacDonell KK, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, & Parsons JT (2018) Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART). JMIR research protocols. 7(12):e11183. doi: 10.2196/11183 - DOI - PMC - PubMed
    1. Bonner K, Mezochow A, Roberts T, Ford N, & Cohn J (2013) Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 64(1):74–8. doi: 10.1097/QAI.0b013e31829f05ac - DOI - PubMed
    1. Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, & Anderson PL (2013) Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 29(2):384–90. doi: 10.1089/AID.2012.0089. Epub 2012 Oct 10 - DOI - PMC - PubMed
    1. Ceffa S, Luhanga R, Andreotti M, Brambilla D, Erba F, Jere H, Mancinelli S, Giuliano M, Palombi L, & Marazzi MC (2016) Comparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection. J Virol Methods. 229:35–9. doi: 10.1016/j.jviromet.2015.12.007 - DOI - PubMed

Publication types

Associated data